Suicide inhibitors of cytochrome P450 1A1 and P450 2B1
- PMID: 1510726
- DOI: 10.1016/0006-2952(92)90417-h
Suicide inhibitors of cytochrome P450 1A1 and P450 2B1
Abstract
The inhibition of the P450 1A1 dependent de-ethylation of 7-ethoxyphenoxazone (7EPO) and the P450 2B1 dependent de-pentylation of 7-pentoxyphenoxazone (7PPO) by 1-ethynylnaphthalene (1EN), 2-ethynylnaphthalene (2EN), 1-ethynylanthracene (1EA), 2-ethynylanthracene (2EA), 9-ethynylanthracene (9EA), 2-ethynylphenathrene (2EPh), 3-ethynylphenanthrene (3EPh), 9-ethynylphenanthrene (9EPh), 1-ethynylpyrene (1EP) and 2-ethynylpyrene (2EP) was studied in hepatic microsomal preparations from rats. Although all of the polycyclic aromatic acetylenes studied inhibited the dealkylation of 7EPO or 7PPO, only some of the acetylenes produced a mechanism-based irreversible inactivation (suicide inhibition) of the P450 dependent dealkylation of 7EPO or 7PPO. Of the molecules tested, only 1EP, 1EN, 2EN, 2EPh and 3EPh were effective suicide inhibitors of the P450 1A1 dependent de-ethylation of 7EPO and only 1EN, 2EN, 1EA and 9EPh were effective suicide inhibitors of the P450 2B1 dependent de-pentylation of 7PPO. In addition to the size and shape of the polycyclic aromatic ring system, placement of the carbon--carbon triple bond on the ring system was critical for suicide inhibition. In contrast to 1EP, 2EP was not a mechanism-based inhibitor of P450 1A1; 9EPh, but not 2EPh or 3EPh, was a suicide inhibitor of P450 2B1. None of the aryl acetylenes tested produced heme destruction under assay conditions that produced the suicide inhibition of the P450 dependent 7EPO or 7PPO dealkylation activities. Because a precise orientation of the terminal acetylene is required to produce suicide inhibition without heme destruction, acetylenic suicide inhibitors can potentially be used to differentiate between P450 isozymes and to establish some distinguishing geometric features of the active site of these isozymes.
Similar articles
-
Acetylenes: cytochrome P450 oxidation and mechanism-based enzyme inactivation.Drug Metab Rev. 2019 May;51(2):162-177. doi: 10.1080/03602532.2019.1632891. Epub 2019 Jul 7. Drug Metab Rev. 2019. PMID: 31203694 Free PMC article. Review.
-
Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.Chem Res Toxicol. 1997 Jan;10(1):91-102. doi: 10.1021/tx960064g. Chem Res Toxicol. 1997. PMID: 9074808
-
Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynes.Drug Metab Dispos. 1997 Nov;25(11):1242-8. Drug Metab Dispos. 1997. PMID: 9351899 Clinical Trial.
-
Determinants of protein modification versus heme alkylation: inactivation of cytochrome P450 1A1 by 1-ethynylpyrene and phenylacetylene.Chem Res Toxicol. 1993 Jan-Feb;6(1):38-45. doi: 10.1021/tx00031a006. Chem Res Toxicol. 1993. PMID: 8448348
-
Cytochrome P450 family 1 inhibitors and structure-activity relationships.Molecules. 2013 Nov 25;18(12):14470-95. doi: 10.3390/molecules181214470. Molecules. 2013. PMID: 24287985 Free PMC article. Review.
Cited by
-
QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR.SAR QSAR Environ Res. 2011 Oct;22(7-8):681-97. doi: 10.1080/1062936X.2011.623320. Epub 2011 Oct 17. SAR QSAR Environ Res. 2011. PMID: 22004550 Free PMC article.
-
Chemical inactivation of the cinnamate 4-hydroxylase allows for the accumulation of salicylic acid in elicited cells.Plant Physiol. 2002 Oct;130(2):1022-31. doi: 10.1104/pp.004309. Plant Physiol. 2002. PMID: 12376665 Free PMC article.
-
In silico studies of polyaromatic hydrocarbon inhibitors of cytochrome P450 enzymes 1A1, 1A2, 2A6, and 2B1.Chem Res Toxicol. 2010 Mar 15;23(3):600-7. doi: 10.1021/tx900348v. Chem Res Toxicol. 2010. PMID: 20078084 Free PMC article.
-
Development of flavone propargyl ethers as potent and selective inhibitors of cytochrome P450 enzymes 1A1 and 1A2.Drug Metab Lett. 2012;6(4):275-84. doi: 10.2174/1872312811206040007. Drug Metab Lett. 2012. PMID: 23506553 Free PMC article.
-
Acetylenes: cytochrome P450 oxidation and mechanism-based enzyme inactivation.Drug Metab Rev. 2019 May;51(2):162-177. doi: 10.1080/03602532.2019.1632891. Epub 2019 Jul 7. Drug Metab Rev. 2019. PMID: 31203694 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources